Literature DB >> 7916568

Molecular cloning and characterization of a novel transglutaminase cDNA from a human prostate cDNA library.

F J Grant1, D A Taylor, P O Sheppard, S L Mathewes, W Lint, E Vanaja, P D Bishop, P J O'Hara.   

Abstract

The primary sequence of a cDNA encoding a novel transglutaminase from a human prostate cDNA library is reported. The sequence is compared to other known transglutaminases in a multiple alignment. The deduced peptide sequence is 51% identical to a rat prostate transglutaminase.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7916568     DOI： 10.1006/bbrc.1994.2298

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  9 in total

1.  Differential alternative splicing of human transglutaminase 4 in benign prostate hyperplasia and prostate cancer.

Authors:  Sung-Yup Cho; Kyungho Choi; Ju-Hong Jeon; Chai-Wan Kim; Dong-Myung Shin; Jong Bouk Lee; Sang Eun Lee; Choung-Soo Kim; Jeong-Soo Park; Eui Man Jeong; Gi-Yong Jang; Kye-Yong Song; In-Gyu Kim
Journal:  Exp Mol Med       Date:  2010-04-30       Impact factor: 8.718

2.  Physiologic self antigens rapidly capacitate autoimmune disease-specific polyclonal CD4+ CD25+ regulatory T cells.

Authors:  Yulius Y Setiady; Katsuhiro Ohno; Eileen T Samy; Harini Bagavant; Hui Qiao; Colin Sharp; Jin Xiong She; Kenneth S K Tung
Journal:  Blood       Date:  2005-10-13       Impact factor: 22.113

3.  Tissue specific and androgen-regulated expression of human prostate-specific transglutaminase.

Authors:  H J Dubbink; N S Verkaik; P W Faber; J Trapman; F H Schröder; J C Romijn
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

4.  Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium.

Authors:  Werner Baumgartner; Nikola Golenhofen; Agnes Weth; Takashi Hiiragi; Rob Saint; Martin Griffin; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2004-06-25       Impact factor: 4.304

5.  Overexpression of transglutaminase 4 and prostate cancer progression: a potential predictor of less favourable outcomes.

Authors:  Zhi Cao; Yang Wang; Zhi-Yong Liu; Zhen-Sheng Zhang; Shan-Cheng Ren; Yong-Wei Yu; Meng Qiao; Bei-Bei Zhai; Ying-Hao Sun
Journal:  Asian J Androl       Date:  2013-08-26       Impact factor: 3.285

6.  Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.

Authors:  Richard J Ablin; Howard G Kynaston; Malcolm D Mason; Wen G Jiang
Journal:  J Transl Med       Date:  2011-04-28       Impact factor: 5.531

7.  Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain.

Authors:  Wen G Jiang; Lin Ye; Andrew J Sanders; Fiona Ruge; Howard G Kynaston; Richard J Ablin; Malcolm D Mason
Journal:  J Transl Med       Date:  2013-10-25       Impact factor: 5.531

8.  Substrate specificity of microbial transglutaminase as revealed by three-dimensional docking simulation and mutagenesis.

Authors:  Uno Tagami; Nobuhisa Shimba; Mina Nakamura; Kei-Ichi Yokoyama; Ei-Ichiro Suzuki; Takatsugu Hirokawa
Journal:  Protein Eng Des Sel       Date:  2009-10-22       Impact factor: 1.650

9.  Genetic disruption of the copulatory plug in mice leads to severely reduced fertility.

Authors:  Matthew D Dean
Journal:  PLoS Genet       Date:  2013-01-17       Impact factor: 5.917
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.